1,5-anhydroglucitol has been researched along with Liver Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bando, Y; Kanehara, H; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H; Tanaka, N; Toya, D | 1 |
Akanuma, H; Akanuma, Y; Akaoka, I; Nakamura, T; Yamanouchi, T | 1 |
2 other study(ies) available for 1,5-anhydroglucitol and Liver Diseases
Article | Year |
---|---|
1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.
Topics: Blood Glucose; Case-Control Studies; Chronic Disease; Deoxyglucose; Diabetes Complications; Female; Humans; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2011 |
Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Creatinine; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Female; Humans; Isomerism; Liver Diseases; Male; Middle Aged; Obesity; Sex Factors | 1988 |